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Summary
Background: Catastrophic fractures are among the most common cause of fatalities in racehorses. Several factors, including genetics, likely contribute
to increased risk for fatal injuries. A variant in the procollagen-lysine, 2-oxoglutarate 5-dioxygenase1 gene (PLOD1 c.2032G>A) was shown to cause
Warmblood fragile foal syndrome type 1 (WFFS), a fatal recessive defect of the connective tissue. Screening of multiple horse breeds identified the
presence of the WFFS allele in the Thoroughbred. PLOD1 is involved in cross-linking of collagen fibrils and thus could potentially increase the risk of
catastrophic breakdown.
Objectives: Estimate the frequency of the WFFS allele (PLOD1 c.2032G>A) and determine if it is a risk factor for catastrophic breakdown in the
Thoroughbred.
Study design: Case–control genetic study.
Methods: Genomic DNA from hair and/or tissue samples was genotyped for the WFFS allele. Fisher’s Exact tests were performed to compare allele and
carrier frequencies between the case cohort (catastrophic breakdown, n = 22) and several cohorts with no record of injury (n = 138 raced/trained at
same track and season and n = 185 older than 7 years and raced during same season), nonracers (n = 92), and a random sample without
consideration for racing history (n = 279).
Results: The frequency of the PLOD1 c.2032G>A variant in the Thoroughbred breed is low (1.2%). Seventeen of 716 Thoroughbreds tested were
carriers (2.4%) and no WFFS homozygotes were detected. Only one catastrophic breakdown case carried the WFFS allele. No statistically significant
difference in allele or carrier frequency was identified between case and control cohorts (P>0.05 in all comparisons performed).
Main limitations: This study evaluated cases from one single track.
Conclusions: This study demonstrated that the PLOD1 c.2032G>A associated with WFFS is present at very low frequency in Thoroughbreds and is not
a genetic risk factor for catastrophic breakdown.
Keywords: horse; catastrophic breakdown; warmblood fragile foal syndrome; WFFS procollagen lysine 2-oxoglutarate 5-dioxygenase1
Introduction
The Thoroughbred horse is selectively bred for racing performance, among
other traits. Racing, like any other sport, has inherent risk of injuries.
Catastrophic fractures, resulting from significant bone or soft tissue injury,
carry a poor clinical prognosis and are the most common cause of
euthanasia or spontaneous death in racehorses [1,2]. Investigating equine
catastrophic musculoskeletal injury over a span of 27 years from 21
published studies showed a pooled incidence of 1.17 (0.90–1.44, 95% CI)
injuries per 1000 starts [3]. The Equine Injury Database, which tracks the
frequency, types and outcome of racing injuries in the United States across
118 tracks since 2008, recently reported fatality rates for 2018 to be 1.68
per 1000 starts (http://jockeyclub.com/default.asp?section=Advocacy&area=
10).
Given the critical nature of these injuries, numerous epidemiological
studies have focused on identifying key risk factors for racehorse fatality,
with close to 300 different factors investigated. A recent meta-analysis
comparing 65 studies from 1990 to 2017 identified several horse-specific
(age, sex, and race class), race-specific (track conditions, race distance, and
field size) and management-specific (time since previous start, number of
starts, and previous injury, among others) factors that demonstrate
consistent evidence for risk of catastrophic injury at repeatable sites due to
cycle loading of the limbs in high speed work [3]. Data from several studies
support pre-existing lesions at the distal end of metacarpal three or
metatarsal three as a predisposing risk factor for catastrophic fetlock
injuries [4–10]. Cumulative damage of the articular cartilage and
subchondral bone, resulting from repetitive strain, is believed to lead to
risk for impaired bone remodelling and skeletal failure [1,11,12].
Susceptibility to catastrophic fracture may be due to differences among
horses in the rate at which bone remodelling occurs which is hypothesised
to have a genetic basis [13]. The heritability of distal limb fracture was
reported to range from 0.21 to 0.37 [14], supporting an inherited
component and justification for further studies to identify associated or
causal variants that enable marker-assisted selection and identification of
susceptible horses that may benefit from an altered training and racing
regimens. A genome-wide association study identified loci on ECA18 and
ECA1 associated with distal limb fracture [13]. Significant associations with
fracture risk were also reported for loci on ECA8, 22, and 31, based on the
REML analysis. This same study identified several positional candidate
genes involved in bone development, however; to date no causal variants
have been reported [13]. Therefore, the precise role that genetic variants
play in bone metabolism and susceptibility to catastrophic fracture remains
to be investigated.
Several genetic variants identified in the horse have been linked to
connective tissue disorders and these may be important contributors to
catastrophic breakdown. The aims of the current study were to estimate
the allele frequency of one of these variants, namely PLOD1 c.2032G>A
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p.Gly678Arg, in the Thoroughbred population and to determine if allele or
carrier frequency differed between catastrophic breakdown case and
control cohorts. PLOD1 c.2032G>A has been reported to cause
Warmblood fragile foal syndrome type 1 (WFFS) [15]. This syndrome has
been characterised in Warmblood breeds and presents as hyperextensible,
abnormally thin and fragile skin that results in open lesions, as well as, lax
and hyperextensible limb joints [15–18]. Important for collagen
biosynthesis, PLOD1 catalyses the hydroxylation of lysine residues in Xaa-
Lys-Gly-collagen sequences stabilising intermolecular collagen crosslinks
and providing strength and support to many body tissues [19]. Screening
of multiple horse breeds during the commercialisation of this test at the
Veterinary Genetics Laboratory, University of California, Davis, USA (VGL)
identified the presence of the WFFS allele in the Thoroughbred breed. The
presence of this allele in the Thoroughbred, together with the established
role of PLOD1 in proper collagen cross-linking, led to speculation that the
PLOD1 c.2032G>A allele could be associated with catastrophic breakdown
in Thoroughbred horses. In this study, we aimed to determine if the PLOD1
c.2032G>A allele frequency differs between cohorts of Thoroughbred
horses known to have catastrophic injuries during a race or in training
compared with those raced with no record of injury, and those not raced.
Materials and methods
Samples
Case cohort: Twenty-two catastrophic breakdown fatalities were
identified for inclusion in this study (Table 1). To minimise other potential
variables that contribute to catastrophic fracture, cases that occurred
during the racing season (12/2018–3/2019) from a single track were
included. Thirteen horses were injured during a race and nine were injured
during training. Characterisation of injury type is described in Table 2.
Genomic DNA was obtained from either hair (n = 12) banked at the VGL or
kidney tissue obtained from banked samples submitted through the
California Animal Health and Food Safety Laboratory System following the
protocols of California State Racing Board (n = 2) or both hair and kidney
tissue (n = 8). DNA isolation from hair was done as previously described
[20] and from kidney samples using 3 mm of tissue and an alkaline lysis
protocol as described in [21]. To confirm sample ID, DNA samples were
PCR-amplified for horse identification markers using the commercially
available genetic marker test offered at the VGL. All 22 case samples had
genetic profiles on file at the VGL. Sample and horse identification was
confirmed by comparing genetic profiles from the DNA extracted for this
study to those profiles from previous testing performed as part of the
parentage-testing program for The Jockey Club. Additionally, for the eight
samples with both hair and kidney tissue available, genetic profiles were
compared between the DNA extracted from the two tissue types and to
the profile in the database. All samples matched the expected genetic
profile.
Control cohorts: Genomic DNA was isolated from banked hair follicles, as
described above [20], from several control cohorts that included A) horses
that race or trained at the same track and during the same racing season
as the case cohort but with no record of injury (n = 138), B) horses 7 years
of age or older that raced during the same racing season, at any US
racetrack, with no record of injury (n = 185), C) horses that were between
the age of 5–9 that never started in a race (n = 92) and D) random
sampling of Thoroughbreds regardless of racing history or age (n = 279).
Age range and gender distribution of each cohort are reported in Table 1.
No first-degree relatives were included in this study. All of these samples
(with the exception of nine samples in cohort D) had genetic profiles on file
and sample identity was confirmed by matching genetic profiles as
described above.
Genotyping and statistical tests
DNA was amplified for the PLOD1 c.2032G>A variant using the
commercially available assay at the VGL. To ensure accurate genotyping,
assays were run with three positive controls (one for each genotype), and
one negative control (water, no DNA). Positive controls genotyped as
expected and negative controls did not yield detectable PCR product.
Power calculations were performed using a Pearson’s Chi-squared test
with a Cohen’s W calculation and varying sample sizes and allele
frequencies. With a sample size of 200, allele frequency of 0.0575, and a
frequency of cases set at 8% power to detect association is 81.87%.
Therefore, with a total sample set of 716 individuals, even with a low allele
frequency, sufficient power to detect associations should be achieved.
Allele and carrier frequencies were calculated for each cohort and for the
combined data set. Pairwise comparisons between the catastrophic
breakdown cohort and control cohorts were evaluated by Fisher’s Exact
test. Statistical significance was evaluated at both an uncorrected value of
<0.05 (Praw) and Bonferroni corrected value (0.05/6 comparisons) of 0.008
(Pcorrected). Additional comparisons were made between the racing
population and the cohort of horses that did not start in a race as well as
between the racing cohort and the random population.
Results
The WFFS allele (PLOD1 c.2032G>A) was detected in all cohorts at a low
frequency ranging from 0.5 to 1.8% (Table 3). Among all samples, the allele
frequency was 1.2% (Table 3). Of the 716 horses tested in this study, 17
were carriers for the deleterious allele and no horses homozygous for the
variant allele were identified.
Only one horse in 22 catastrophic breakdown cases carried the WFFS
allele. In an attempt to control for other environmental effects, we first
compared the carrier and allele frequencies of the case population to a
cohort of horses racing or training at the same track, during the same
season as the cases (Cohort A; n = 138). There were no statistically
significant differences between these pairwise comparisons (P = 0.5 for
both comparison of allele and carrier frequencies). In evaluating an older
cohort of horses (Cohort B; n = 185) that raced during the same season as
the cases, but at racetracks across the United States, the number of
carriers was not higher compared with the controls (P = 0.3), as might be
expected if heterozygous WFFS horses were more prone to injury. We also
TABLE 1: Case and control cohort information. Presented are
sample size, number of males and females in each cohort, average
age of the animals and age range for the cohort
Cohort
Sample
size Males Females
Average
age
Age
range
Case cohort:
catastrophic
breakdown
22 14 8 4.05 3–7
Control cohort A: same
track and same
season as cases
138 79 59 4.23 3–8
Control cohort B:
horses >7 years old
and raced during
same season as cases
185 132 53 7.62 7–9
Control cohort C: non-
racers
92 40 52 7.06 5–9
Control cohort D:
random population
279 138 141 6.76 1–27
TABLE 2: Catastrophic fracture case cohort. The distribution of
cases and bone or joint involved across all four limbs is
summarised
Injured limb Number of cases Bone or joint involved
Left forelimb 6 Fetlock (n = 5); Carpus (n = 1)
Right forelimb 11 Fetlock (n = 11)
Left hindlimb 3 Metatarsal III (n = 3)
Right hindlimb 2 Metatarsal III (n = 2)
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sought to determine if there was a higher allele or carrier frequency
among horses that did not race (Cohort C), but no significant differences
were detected when comparing nonracers (n = 92) to either the case
cohort (P = 0.4 carrier frequency and 0.3 allele frequency) or the combined
racing cohort (P = 1.00). Finally, to investigate possible sampling biases in
control cohorts, we also compared the allele and carrier frequencies of the
case and the racing cohorts with those of a random sample of
Thoroughbreds with no age criterion and whose racing records were
unknown to the investigators (Cohort D; n = 279). No significant
differences were detected in these comparisons (P = 0.6 for both allele
and carrier frequency comparisons between cases and Cohort D and
P = 0.2 for the comparisons between all racing cohorts and Cohort D). All
association tests performed did not achieve a statistically significant
probability value for the Bonferroni corrected Pcorrected cut-off.
Discussion
The objective of this study was to estimate the PLOD1 c.2032G>A allele
frequency in the Thoroughbred breed and to determine if this allele was
associated with catastrophic injury. By examining 716 horses, we
confirmed the frequency of the PLOD1 c.2032G>A variant to be low in all
cohorts that we screened. Furthermore, these data do not support the
WFFS allele as a risk factor for catastrophic breakdown. Specifically,
differences were not detected in the PLOD1 c.2032G>A allele or carrier
frequencies between any of the cohorts under investigation. While cases
from a single racetrack were analysed, the low allele frequency in each of
the cohorts and in the combined data set makes it highly unlikely that this
PLOD1 variant plays a role in catastrophic breakdown.
This PLOD1 variant has been shown to cause a condition in Warmblood
breeds similar to what has been described in humans as Ehlers-Danlos
syndrome, with fragile skin and lax and hyperextensible joints. The original
study identifying the PLOD1 c.2032G>A variant was described in a patent
application that reported two clinically WFFS-affected horses homozygous
for the variant (A/A), eight carriers (G/A) reported as clinically normal and
149 horses homozygous for the “G” allele, also clinically normal
(International patent number WO 2012/158711). A subsequent clinical case
report identified a third affected foal who was also homozygous for the
PLOD1 variant and was euthanised because of poor prognosis [15]. In
humans, over 40 mutations in PLOD1 have been reported to cause Ehlers-
Danlos syndrome, kyphoscoliotic type 1. Some human patients show
features of joint laxity and skin fragility, similar to WFFS in horse, while
others are characterised by these and/or other clinical symptoms including
congenital muscle hypotonia, congenital or early onset kyphoscoliosis, and
scleral fragility and rupture of the globe of the eye [22–24]. It is unknown if
additional mutations are present in horse PLOD1 that result in similar
phenotypes.
Seventeen of 716 horses studied were carriers of this variant and no
horse in this study was homozygous for the mutation. Based on the overall
allele frequency of 1.2%, the expected incidence of WFFS in the
Thoroughbred would be 1–2 horses in 10,000 births. With approximately
20,000 foals registered annually in the US [25] this would correspond to
four cases each year. No cases of WFFS have been reported in
Thoroughbred horses. However, one Ehlers-Danlos Like Syndrome
Thoroughbred case was reported in 1984 [26]. Although there are multiple
genetic causes of Ehlers-Danlos Like Syndromes this particular case, being
an older horse with symptoms not as severe as those described for the
WFFS mutation, makes it unlikely that it represents the same disease
reported in Warmblood breeds [15]. Given that there are no reported cases
that clinically resemble WFFS in the Thoroughbred, despite the presence of
the allele in the breed, albeit at a low frequency, it is plausible, that
homozygosity for PLOD1 c.2032G>A may result in early embryonic loss. In
support of this, a recent study reported the frequency of the WFFS allele in
Warmblood horses in Brazil to be 5.5%, with no live homozygotes and no
reported WFFS cases in the country [27]. The frequency of the PLOD1
variant in Warmbloods from other countries has not been reported. In
addition, if homozygosity causes early embryonic loss in these breeds is
yet to be investigated. Therefore, more work is needed to estimate allele
frequency across breeds and investigate the embryonic loss hypothesis in
horse breeds that possess the PLOD1 c.2032G>A allele.
Heritability and genome-wide association studies provide evidence that
genetics plays a role in bone remodelling that contribute to catastrophic
injury [13,14]. The present study determined that the PLOD1 c.2032G>A
variant is not a contributor to catastrophic injuries in the racing
Thoroughbred. Therefore, the precise genetic variants that contribute to
variation in bone remodelling remain to be identified.
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TABLE 3: Genotyping results for the Warmblood fragile foal mutation (PLOD1 c.2031G>A) in case and control cohorts of Thoroughbred
horses. Presented are sample size, genotypes, and allele and carrier frequency for each cohort and the total population under
investigation
Cohorts
Sample
Size
WFFS genotype
Allele
frequency
Carrier
frequencyN/N
N/
WFFS
WFFS/
WFFS
Case cohort: catastrophic breakdown 22 21 1 0 0.023 0.045
Control cohort A: same track and same season as cases 138 135 3 0 0.011 0.022
Control cohort B: horses >7 years old and raced during same season as
cases
185 183 2 0 0.005 0.011
Control cohort C: nonracers 92 91 1 0 0.005 0.011
Control cohort D: random population 279 269 10 0 0.018 0.036
Combined data 716 699 17 0 0.012 0.024
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